Skip to main content
. 2023 May 9;24(10):8509. doi: 10.3390/ijms24108509

Figure 4.

Figure 4

(a) 15-F2t-Isprostane (15-F2t-IsoP), (b) 9-hydroxyeicosatetraenoic acid (9-HETE), normalized with arachidonic acid concentrations of control (C) and intervention (I) groups at baseline and endpoint.